NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K Filing

NeuroOne reports preliminary FY2026 revenue of $10.5M and Q4 product revenue growth of 38.4% to $3.8M; secures record $4.5M purchase order (Items: 2.02 Results of Operations and Financial Condition, 8.01 Other Events Preliminary Results On October 5, 2026, the Company reported the following preliminary, unaudited fiscal year 2026 financial and, 9.01 Financial Statements and Exhibits)

SEC EDGAR · October 5, 2026, 13:21 UTC

Tickers: $NMTC

Read the full article at SEC EDGAR

More Regulatory news

UNITED BANCORP INC /OH/ - 10-Q Filing SEC EDGAR · November 12, 2026, 15:33 UTC
PATRIOT GOLD CORP - 10-Q Filing SEC EDGAR · November 12, 2026, 15:32 UTC
First Digital Acquisition Corp Ltd. - 8-K Filing SEC EDGAR · November 12, 2026, 15:29 UTC
GROOVE BOTANICALS INC. - 10-Q Filing SEC EDGAR · November 12, 2026, 15:24 UTC
Johnson Controls International plc - 10-K Filing SEC EDGAR · November 12, 2026, 15:24 UTC
OLD NATIONAL BANCORP /IN/ - 8-K Filing SEC EDGAR · November 12, 2026, 15:20 UTC
AMTECH SYSTEMS INC - 8-K Filing SEC EDGAR · November 12, 2026, 15:16 UTC
REGIONAL HEALTH PROPERTIES, INC - 8-K Filing SEC EDGAR · November 12, 2026, 15:09 UTC
Bitwise Avalanche ETF - 8-K Filing SEC EDGAR · November 12, 2026, 15:06 UTC
MiNK Therapeutics, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 15:05 UTC